American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines

Author:

Alger Heather M.1ORCID,Rutan Christine1,Williams Joseph H.1,Walchok Jason G.1,Bolles Michele1,Hall Jennifer L.12,Bradley Steven M.3,Elkind Mitchell S. V.45,Rodriguez Fatima6,Wang Tracy Y.7,Morrow David A.8,Das Sandeep R.9,de Lemos James A.9

Affiliation:

1. Quality, Outcomes Research and Analytics Department, American Heart Association, Dallas, TX (H.M.A., C.R., J.H.W., J.G.W., M.B., J.L.H.).

2. University of Minnesota, Minneapolis, MN (J.L.H.).

3. Healthcare Delivery Innovation Center; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN (S.M.B.).

4. Vagelos College of Physicians and Surgeons and Mailman School of Public Health, Columbia University, New York, NY (M.S.V.E.).

5. New York-Presbyterian Hospital New York (M.S.V.E.).

6. Stanford University School of Medicine, Palo Alto, CA (F.R.).

7. Duke Clinical Research Institute, Duke University, Durham, NC (T.Y.W.).

8. Levine Cardiac Intensive Care Unit, Harvard Medical School, Boston, MA (D.A.M.).

9. UT Southwestern Medical Center, Dallas, TX (S.R.D., J.A.d.L.).

Abstract

Background: In response to the public health emergency created by the coronavirus disease 2019 (COVID-19) pandemic, American Heart Association volunteers and staff aimed to rapidly develop and launch a resource for the medical and research community to expedite scientific advancement through shared learning, quality improvement, and research. In <4 weeks after it was first announced on April 3, 2020, AHA’s COVID-19 CVD Registry powered by Get With The Guidelines received its first clinical records. Methods and Results: Participating hospitals are enrolling consecutive hospitalized patients with active COVID-19 disease, regardless of CVD status. This hospital quality improvement program will allow participating hospitals and health systems to evaluate patient-level data including mortality rates, intensive care unit bed days, and ventilator days from individual review of electronic medical records of sequential adult patients with active COVID-19 infection. Participating sites can leverage these data for onsite, rapid quality improvement, and benchmarking versus other institutions. After 9 weeks, >130 sites have enrolled in the program and >4000 records have been abstracted in the national dataset. Additionally, the aggregate dataset will be a valuable data resource for the medical research community. Conclusions: The AHA COVID-19 CVD Registry will support greater understanding of the impact of COVID-19 on cardiovascular disease and will inform best practices for evaluation and management of patients with COVID-19.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3